Instill one drop into the conjunctival sac two to four times daily. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after two days, the patient should be    re-evaluated (see PRECAUTIONS).
The dosing of FML FORTEÂ® (fluorometholone ophthalmic suspension 0.25%)  suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.
